Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study

Table 2 Adverse Effects in Patients Receiving Tripterygium Wilfordii Multiglycosides or Tacrolimus

	TAC group (n = 30)	TWG group (n = 23)
Leukopenia	0	0
Anaemia	2 (6.7 %)	1 (4.3 %)
New-onset glucose intolerance	2 (6.7 %)	0
New-onset hypertension	0	0
Liver injury	0	0
Infections	0	0
Bacterial pneumonia	0	0
Gastrointestinal symptoms	3 (10 %)	2 (8.7 %)
Menstrual disorder	0	3 (13.0 %)

ISSN: 1471-2369